Do you want to read an article? Please log in or register.
Incidence and reasons for discontinuation of anti-VEGF treatment in neovascular age-related macular degeneration
Macular Diseases
Related content
Macular Diseases
Adherence to Anti-VEGF Treatment in Patients with Neovascular Age-Related Macular Degeneration: A Real-World Study
Ophthalmol Ther
Shellvarajah M, Nguyen V, Steinmann S, Gillies MC, Sagkriotis A, Barthelmes D
doi: 10.1007/s40123-025-01140-z
Macular DiseasesRetinal Diseases
Persistence of Retinal Fluid after Anti-VEGF treatment for neovascular age-related macular degeneration: A Systematic Review and Meta-Analysis
Ophthalmol Retina
Ting Yap DW, Jyn Tan BK, Yi Chong KT, Wong TY, Gemmy Cheung CM
doi: 10.1016/j.oret.2025.01.010
Macular Diseases
Choroidal thickness after anti-VEGF in typical neovascular age-related macular degeneration - A systematic review and meta-analysis
Surv Ophthalmol
Hoven E, Michelet JT, Vettore MV, Lagali N
doi: 10.1016/j.survophthal.2024.09.011
Macular Diseases
Real-World 10-Year Outcomes of Anti-VEGF Therapy for Neovascular Age-Related Macular Degeneration: A Meta-Analysis
Clin Exp Ophthalmol
Spooner K, Broadhead G, Fraser-Bell S, Hong T, Wong JG, Chang AA
doi: 10.1111/ceo.14559
Macular Diseases
Comparative efficacy of intravitreal anti-VEGF therapy for neovascular age-related macular degeneration: A systematic review with network meta-analysis
Acta Ophthalmol
Butler ETS, Arnold-Vangsted A, Schou MG, Anguita R, Bjerager J, Borrelli E, Cehofski LJ, Ferro Desideri L, van Dijk EHC, Faber C, Grauslund J, Hajari JN, Huemer J, Klefter ON, Krogh Nielsen M, Sabaner MC, Schneider M, Subhi Y
doi: 10.1111/aos.17506
RECOMMENDED
Macular Diseases
Macular Atrophy in Neovascular Age-Related Macular Degeneration: A Systematic Review and Meta-Analysis
★ 3
Recommended by
Prof. emer. Dr Josef Flammer, Faculty Member
Ophthalmol Retina
Berni A, Coletto A, Li J, Shen M, Bandello F, Reibaldi M, Borrelli E
doi: 10.1016/j.oret.2025.01.011
Macular Diseases
Intravitreal anti-vascular endothelial growth factor injections and risks of stroke in patients with neovascular age-related macular degeneration-A registry-based cohort study
Acta Ophthalmol
Falemban AH, Söderberg-Löfdal K, Jonsson F, Almlöf-Sarman S, von Euler M, Westborg I
doi: 10.1111/aos.17534
Macular Diseases
Real-World 5-Year Outcomes of Age-Related Macular Degeneration with Bevacizumab as First-Line Anti-VEGF
Ophthalmol Ther
Mhmud H, Vermeulen JP, Tigchelaar-Besling OAM, Verbraak FD, Barthelmes D, Gillies M, Ponsioen TL, Klaver CCW
doi: 10.1007/s40123-025-01178-z
Macular Diseases
Outlier ophthalmologists in the treatment of neovascular age-related macular degeneration with intravitreal therapy
Br J Ophthalmol
Hashimoto Y, Hunt AR, Wells JM, Banerjee G, Ferrier R, Barry R, Field A, Game J, Hooper CY, Barthelmes D, Gillies MC
doi: 10.1136/bjo-2024-326024